This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Anges Mg, Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: **Naruya Tomita: Innovator in Oligonucleotide Technologies**
Introduction
Naruya Tomita, based in Osaka, Japan, is a distinguished inventor known for his significant contribution in the field of oligonucleotides. With a focus on improving the stability and efficacy of these molecules, he has developed innovative solutions that have the potential to transform therapeutic applications.
Latest Patents
Tomita holds a patent for "Staple type oligonucleotide and drug comprising the same." His invention addresses the instability of conventional oligonucleotides, which are typically open at both ends and prone to degradation. The patent highlights the improvement in stability achieved through novel modifications that circumvent the toxicity associated with phosphorothioate. This groundbreaking work includes the development of transcription factor inhibitors, antisense oligonucleotides, and siRNAs. His innovations are focused on creating agents for preventing, treating, or improving various medical conditions, including inflammation, autoimmune diseases, and renal disorders.
Career Highlights
Naruya Tomita is associated with Anges Mg, Inc., where he applies his expertise to advance research and product development in biotechnology. His contributions have been instrumental in addressing critical medical challenges, showcasing his dedication to innovation and healthcare improvement.
Collaborations
Throughout his career, Tomita has collaborated with notable professionals in the field, including Yasuo Kunugiza and Hideo Hashimoto. These collaborations have not only enriched his research but have also fostered innovation within the development of new therapeutic strategies.
Conclusion
Naruya Tomita exemplifies the role of inventors in driving scientific advancements. Through his innovative work in oligonucleotide technology, he continues to pave the way for new therapeutic options that aim to enhance patient care and treatment outcomes. His dedication to overcoming challenges in biotechnology marks him as a leading figure in the realm of medical inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile